Justin Du Bois
Fondateur chez SiteOne Therapeutics, Inc.
Profil
Justin Du Bois is the founder of SiteOne Therapeutics, Inc. which was founded in 2010.
He held the title of Director since the founding.
Dr. Du Bois has a doctorate from Massachusetts Institute of Technology and an undergraduate degree from the University of California, Berkeley.
Postes actifs de Justin Du Bois
Sociétés | Poste | Début |
---|---|---|
SiteOne Therapeutics, Inc.
SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Fondateur | 01/01/2010 |
Formation de Justin Du Bois
University of California, Berkeley | Undergraduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
SiteOne Therapeutics, Inc.
SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Health Technology |